Symcel this week introduced a new platform called calScreener that can provide real-time cellular bioenergetic measurements of 32 samples at a time.

Magnus Jansson, CSO at the Stockholm -based company, told BioArray News that Symcel will initially be targeting pharmaceutical, biotechnology, and academic customers in Europe, its home market, ahead of a planned US launch next year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.